Future treatments for Sjögren's syndrome

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Primary Sjögren's syndrome (pSS) is a chronic, progressive, multi-organ autoimmune disorder.
• The treat-to-target approach aims to personalize treatment by addressing specific molecular mechanisms of disease.
• Current therapeutic options for pSS primarily focus on symptom management.

Purpose of the Study:

• To review the immunopathology of pSS.
• To discuss current and emerging treatment strategies for pSS.
• To highlight unmet needs and future research directions in pSS treatment.

Main Methods:

• Literature review of immunopathology and treatment approaches for pSS.
• Analysis of current clinical trial data for novel therapies.
• Discussion of challenges and opportunities in pSS research.

Main Results:

• B-cell depletion is the most investigated novel treatment, but data are insufficient for routine clinical application.
• Understanding pSS pathophysiology is advancing.
• Validated endpoints for treatment efficacy are still under development.

Conclusions:

• There is a significant unmet need for effective treatments for pSS.
• Further research, including randomized controlled trials, is crucial for developing targeted therapies.
• Identifying patient subgroups who may benefit from specific treatments like B-cell depletion is a future goal.